Inhalation therapy in patients receiving mechanical ventilation: An update

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 6, 2012, Pages 319-332

  Ari, Arzu ^a   Fink, James B ^a   Dhand, Rajiv ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

aerosols; mechanical ventilation; metered dose inhalers; nebulizers

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BECLOMETASONE; BUDESONIDE; CHLOROFLUOROCARBON; DIURETIC AGENT; DORNASE ALFA; FENOTEROL; FLUTICASONE; FORMOTEROL; HEPARIN; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; ORCIPRENALINE; PROSTACYCLIN; PROSTAGLANDIN; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SURFACTANT; TERBUTALINE;

ABSORPTION; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; ASTHMA; BREATHING PATTERN; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG URINE LEVEL; ENDOTRACHEAL TUBE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMIDIFIER; IN VITRO STUDY; IN VIVO STUDY; INTENSIVE CARE UNIT; INTESTINE ABSORPTION; METERED DOSE INHALER; MUCOCILIARY CLEARANCE; NEBULIZATION; NEBULIZER; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY TRACT MUCOSA; REVIEW; TACHYCARDIA; TUBE; WHEEZING;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; BRONCHODILATOR AGENTS; CRITICAL ILLNESS; DRUG DELIVERY SYSTEMS; HUMANS; INTENSIVE CARE UNITS; LUNG; NEBULIZERS AND VAPORIZERS; RESPIRATION, ARTIFICIAL; TISSUE DISTRIBUTION;

EID: 84870437433     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0936     Document Type: Review

References (111)

1. American Association for Respiratory Care: Aerosol consensus conference statement - 1991. Respir Care. ;36:916-921.
2. MacIntyre NR, Silver RM, Miller CW, Schuler F, and Coleman RE: Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med. 1985;13:81-84.
3. Dhand R: Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients. Respir Care. 2005;50:1331-1334.
4. Dhand R: Basic techniques for aerosol delivery during mechanical ventilation. Respir Care. 2004;49:611-622.
5. Fink J, Dhand R, Duarte A, Jenne J, and Tobin M: Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in-vitro model. Am J Respir Crit Care Med. ;154:382-387.
6. Fink JB, Dhand R, Grychowski J, Fahey PJ, and Tobin MJ: Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med. 1999;159:63-68.
7. Vecellio L, Guerin C, Grimbert D, De Monte M, and Diot P: In vitro study and semiempirical model for aerosol delivery control during mechanical ventilation. Intensive Care Med. ;31:871-876.
8. Dhand R, and Tobin MJ: Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med. 1997;156:3-10.
9. Dhand R: Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. ;47:1406-1416.
10. Dolovich MB, and Dhand R: Aerosol drug delivery: Developments in device design and clinical use. Lancet. ;377:1032-1045.
11. Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H, European Respiratory Society, and International Society for Aerosols in Medicine: What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308-1331.
12. Georgopoulos D, Mouloudi E, Kondili E, and Klimathianaki M: Bronchodilator delivery with metered-dose inhaler during mechanical ventilation. Crit Care. 2000;4:227-234.
13. Ari A, Hess D, Myers TR, and Rau JL: A Guide to Aerosol Delivery Devices for Respiratory Therapists. American Association for Respiratory Care, Dallas, Texas; pp. 1-43, 2009.
14. Rau JL: The inhalation of drugs: Advantages and problems. Respir Care. 2005;50:367-382.
15. Hess DR: Aerosol delivery devices in the treatment of asthma. Respir Care. 2008;53:699-723.
16. Rubin BK: Air and soul: The science and application of aerosol therapy. Respir Care. 2010;55:911-921.
17. Ari A, Areabi H, and Fink JB: Evaluation of position of aerosol device in two different ventilator circuits during mechanical ventilation. Respir Care. 2010;55:837-844.
18. Rau J, Harwood R, and Groff J: Evaluation of a reservoir device for metered-dose bronchodilator delivery to intubated adults: An in-vitro study. Chest. 1992;102:924-930.
19. Taylor RH, Lerman J, Chambers C, and Dolovich M: Dosing efficiency and particle-size characteristics of pressurized metered-dose inhaler aerosols in narrow catheters. Chest. 1993;103:920-924.
20. Diot P, Morra L, and Smaldone GC: Albuterol delivery in a model of mechanical ventilation. Comparison of metereddose inhaler and nebulizer efficiency. Am J Respir Crit Care Med. 1995;152(Pt 1):1391-1394.
21. Fuller HD, Dolovich MB, Posmituck G, Pack WW, and Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs. Am Rev Respir Dis. 1990;141:440-444.
22. Alzahrani W, Harwood R, Fink J, Goodfellow L, and Ari A: Comparison of albuterol delivery during high frequency oscillatory ventilation and conventional mechanical ventilation of a simulated adult. Respiratory Care. 2010;55: 1576.
23. Branconnier M, and Hess D: Albuterol delivery during noninvasive ventilation. Respir Care. 2005;50:1649-1653.
24. Fink J: Metered-dose inhalers, dry powder inhalers and transitions. Respir Care. 2000;45:623-635.
25. Everard ML, Devadason SG, Summers QA, and Le Souef PN: Factors affecting total and ''respirable'' dose delivered by a salbutamol metered dose inhaler. Thorax. 1995;50:746-749.
26. Dhand R, Jubran A, and Tobin MJ: Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med. 1995;151:1827-1833.
27. Fuller HD, Dolovich MB, Turpie FH, and Newhouse MT: Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients. A study comparing four different actuator devices. Chest. 1994;105:214-218.
28. Rau J, Dunlevy C, and Hill R: A comparison of inline MDI actuators for delivery of a beta agonist and a corticosteroid with a mechanically-ventilated lung model. Respir Care. ;43:705-712.
29. Dhand R, Duarte A, Jubran A, Jenne JW, Fink JB, Fahey PJ, and Tobin MJ: Dose response to bronchodilator delivered by metered-dose inhaler in ventilator supported patients. Am J Respir Crit Care Med. 1996;154:388-393.
30. O'Riordan TG, Greco MJ, Perry RJ, and Smaldone GC: Nebulizer function during mechanical ventilation. Am Rev Respir Dis. 1992;145:1117-1122.
31. Garner SS, Wiest DB, and Bradley JW: Albuterol delivery by metered-dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy. 1994;14:210-214.
32. Ari A, and Fink JB: Factors affecting bronchodilator delivery in mechanically ventilated adults. Nurs Crit Care. ;15:192-203.
33. Lange C, and Finlay W: Overcoming the adverse effect of humidity in aerosol delivery via pressurized metered-dose inhalers during mechanical ventilation. Am J Respir Crit Care Med. 2000;161:1614-1618.
34. Dhand R: New frontiers in aerosol delivery during mechanical ventilation. Respir Care. 2004;49:666-677.
35. Lin HL, Fink JB, Zhou Y, and Cheng YS: Influence of moisture accumulation in inline spacer on delivery of aerosol using metered-dose inhaler during mechanical ventilation. Respir Care. 2009;54:1336-1341.
36. Dhand R: Aerosol delivery during mechanical ventilation: From basic techniques to new devices. J Aerosol Med. 2008; 21:45-60.
37. Ari A, and Fink J: Aerosol drug delivery administration with helium-oxygen (heliox) mixtures: An overview. Curr Respir Med Rev. 2010;6:80-85.
38. Svartengren M, Anderson M, Philipson K, and Camner P: Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res. 1989;15:575-585.
39. Goode ML, Fink JB, Dhand R, and Tobin MJ: Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med. 2001; 163:109-114.
40. Duarte AG: Inhaled bronchodilator administration during mechanical ventilation. Respir Care. 2004;49:623-634.
41. Hess DR, Acosta FL, Ritz RH, Kacmarek RM, Camargo CA Jr. The effect of heliox on nebulizer function using a betaagonist bronchodilator. Chest. 1999;115:184-189.
42. Tassaux D, Jolliet P, Thouret JM, Roeseler J, Dorne R, and Chevrolet JC: Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Am J Respir Crit Care Med. 1999;160:22-32.
43. Rau JL: Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47:1257-1275.
44. Hess DR: Nebulizers: Principles and performance. Respir Care. 2000;45:609-622.
45. Dhand R, and Sohal H: Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients. Expert Rev Med Devices. 2008;5:9-20.
46. Phipps P, and Gonda I: Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest. 1990;97:1327-1332.
47. Steckel H, and Eskandar F: Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. Eur J Pharm Sci. 2003;19:443-455.
48. Watts AB, McConville JT, and Williams RO 3rd: Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev Ind Pharm. 2008;34:913-922.
49. Ruickbie S, Hall A, and Ball J: Therapeutic aerosols in mechanically ventiltated patients. In: J Vincent (ed). Annual Update in Intensive Care and Emergency Medicine 2011. Springer, Berlin; pp. 197-206, 2011.
50. Perera AD, Kapitza C, Nosek L, Fishman RS, Shapiro DA, Heise T, and Heinemann L: Absorption and metabolic effect of inhaled insulin: Intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes. Diabetes Care. 2002;25:2276-2281.
51. Alvine GF, Rodgers P, Fitzsimmons KM, and Ahrens RC: Disposable jet nebulizers. How reliable are they Chest. ;101:316-319.
52. Hess D, Fisher D, Williams P, Pooler S, and Kacmarek RM: Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110: 498-505.
53. Ari A, Atalay OT, Harwood R, Sheard MM, Aljamhan EA, and Fink JB: Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care. 2010;55:845-851.
54. Waldrep JC, and Dhand R: Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5:114-119.
55. Harvey C, O'Doherty M, Page C, Thomas S, Nunan T, and Treacher D: Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J. 1997;10:905-909.
56. Pitance L, Vecellio L, Leal T, Reychler G, Reychler H, and Liistro G: Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. J Aerosol Med Pulm Drug Deliv. 2010;23:389-396.
57. Loffert DT, Ikle D, and Nelson HS: A comparison of commercial jet nebulizers. Chest. 1994;106:1788-1792.
58. Phillips G, and Millard F: The therapeutic use of ultrasonic nebulizers in acute asthma. Respir Med. 1994;88:387-389.
59. Thomas SH, O'Doherty MJ, Page CJ, Treacher DF, and Nunan TO: Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Resp Dis. 1993;148:872-877.
60. Hughes J, and Saez J: Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care. 1987;32:1131-1135.
61. O'Doherty MJ, Thomas SH, Page CJ, Treacher DF, and Nunan TO: Delivery of a nebulized aerosol to a lung model during mechanical ventilation. Effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis. 1992;146:383-388.
62. Moraine J, Truflandier K, Vandenbergen N, Berre J, Melot C, and Vincent J: Placement of the nebulizer before the humidifier during mechanical ventilation: Effect on aerosol delivery. Heart Lung. 2009;38:435-439.
63. Miller DD, Amin MM, Palmer LB, Shah AR, and Smaldone GC: Aerosol delivery and modern mechanical ventilation: In vitro/in vivo evaluation. Am J Respir Crit Care Med. ;168:1205-1209.
64. Dhand R: Aerosol therapy during mechanical ventilation: Getting ready for prime time. Am J Respir Crit Care Med. ;168:1148-1149.
65. Dhand R, and Guntur VP: How best to deliver aerosol medications to mechanically ventilated patients. Clin Chest Med. 2008;29:277-296.
66. Dellweg D, Wachtel H, Hohn E, Pieper MP, Barchfeld T, Ko hler D, and Glaab T: In vitro validation of a respimat/adapter for delivery of inhaled bronchodilators during mechanical ventilation. J Aerosol Med. 2011;24:285-292.
67. O'Riordan TG, Palmer LB, and Smaldone GC: Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med. 1994;149: 214-219.
68. Newman S, Pavia D, Moren F, Sheahan N, and Clarke SW: Deposition of pressurised aerosols in the human respiratory tract. Thorax. 1981;36:52-55.
69. Dolovich M, Ruffin RE, Roberts R, and Newhouse MT: Optimal delivery of aerosols from metered dose inhalers. Chest. 1981;80(Suppl 6):911-915.
70. Duarte A, Dhand R, Reid D, Tobin M, and Jenne J: Serum salbutamol levels after metered-dose inhaler administration to ventilated patients and healthy controls. Am J Respir Crit Care Med. 1996;154:1658-1663.
71. Marik P, Hogan J, and Krikorian J: A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients. Chest. 1999;115:1653-1657.
72. Guerin C, Fassier T, Bayle F, Lemasson S, and Richard J: Inhaled bronchodilator administration during mechanical ventilation: How to optimize it and for which clinical benefit J Aerosol Med. 2008;21:85-95.
73. Boucher RC: Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med. ;261:5-16.
74. Fresoli RP, Smith RM Jr, Young JA, and Gottshall SC: Use of aerosol isoproterenol in an anesthesia circuit. Anesth Analg. 1968;47:127-132.
75. Gold MI: Treatment of bronchospasm during anesthesia. Anesth Analg. 1975;54:783-786.
76. Gay PC, Rodarte JR, Tayyab M, and Hubmayr RD: Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am Rev Respir Dis. 1987;136:880-885.
77. Wegener T, Wretman S, Sandhagen B, and Nystrom SO: Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment. Acta Anaesthesiol Scand. 1987;31:652-654.
78. Bernasconi M, Brandolese R, Poggi R, Manzin E, and Rossi A: DoseYresponse effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Care Med. 1990;16: 108-114.
79. Fernandez A, Lazaro A, Garcia A, Aragon C, and Cerda E: Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers. Am Rev Respir Dis. 1990;141:164-168.
80. Gay PC, Patel HG, Nelson SB, Gilles B, and Hubmayr RD: Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest. 1991;99: 66-71.
81. Mancebo J, Amaro P, Lorino H, Lemaire F, Harf A, and Brochard L: Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis. 1991;144:95-100.
82. Manthous C, Hall C, Schmidt G, and Wood L: Metereddose inhaler versus nebulized salbutamol in mechanically ventilated patients. Am Rev Resp Dis. 1993;148:1567-1570.
83. Yang SC, Yang SP, and Lee TS: Nebulized ipratropium bromide in ventilator-assisted patients with chronic bronchitis. Chest. 1994;105:1511-1515.
84. Mouloudi E, Katsanoulas K, Anastasaki M, Askitopoulou E, and Georgopoulos D: Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: Influence of end-inspiratory pause. Eur Respir J. ;12:165-169.
85. Waugh JB, Jones DF, Aranson R, and Honig EG: Bronchodilator response with use of OptiVent versus Aerosol Cloud Enhancer metered-dose inhaler spacers in patients receiving ventilatory assistance. Heart Lung. 1998;27:418-423.
86. Guerin C, Chevre A, Dessirier P, Poncet T, Becquemin MH, Dequin PF, Le Guellec C, Jacques D, and Fournier G: Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(Pt 1):1036-1042.
87. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, and Georgopoulos D: Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: Influence of tidal volume. Intensive Care Med. 1999;25:1215-1221.
88. Duarte A, Momi K, and Bidani A: Bronchodilator therapy with metered dose inhaler and spacer versus nebulizer in mechanically ventilated patients: Comparison of magnitude and duration of response. Respir Care. 2000;45:817-823.
89. Mouloudi E, Prinianakis G, Kondili E, and Georgopoulos D: Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: Influence of flow pattern. Eur Respir J. 2000;16:263-268.
90. Mouloudi E, Maliotakis C, and Kondili E: Duration of salbutamol-induced bronchodilation delivered by metereddose inhaler in mechanically ventilated COPD patients. Monaldi Arch Chest Dis. 2001;56:189-194.
91. Tzoufi M, Mentzelopoulos SD, Roussos C, and Armaganidis A: The effects of nebulized salbutamol, external positive end-expiratory pressure, and their combination on respiratory mechanics, hemodynamics, and gas exchange in mechanically ventilated chronic obstructive pulmonary disease patients. Anesth Analg. 2005;101:843-850.
92. Malliotakis P, Mouloudi E, Prinianakis G, Kondili E, and Georgopoulos D: Influence of respiratory efforts on b2-agonist induced bronchodilation in mechanically ventilated COPD patients: A prospective clinical study. Respir Med. ;101:300-307.
93. Malliotakis P, Linardakis M, Gavriilidis G, and Georgopoulos D: Duration of salmeterol-induced bronchodilation in mechanically ventilated chronic obstructive pulmonary disease patients: A prospective clinical study. Crit Care. ;12:R140.
94. Fernandez A, Munoz J, de la Calle B, Alia I, Ezpeleta A, de la Cal MA, and Reyes A: Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med. 1994;20:199-202.
95. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, and Lalloo UG: Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: A randomised controlled, double-blind study. Lancet. 2006; 368:744-753.
96. Nava S, and Compagnoni ML: Controlled short-term trial of fluticasone propionate in ventilator-dependent patients with COPD. Chest. 2000;118:990-999.
97. Rodrigo GJ: Rapid effects of inhaled corticosteroids in acute asthma: An evidence-based evaluation. Chest. 2006;130: 1301-1311.
98. Morice AH, Morris D, and Lawson-Matthew P: A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease. Clin Pharmacol Ther. 1996;60:675-678.
99. Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB, and Duroux P: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial. Am J Respir Crit Care Med. ;165:698-703.
100. Mirici A, and Akgun M: Comparison of the efficacy of nebulized budesonide with parenteral corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clin Drug Invest. 2003;23:55-62.
101. Ernst P, Gonzalez A, Brassard P, and Suissa S: Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med. 2007;176:162-166.
102. Guerin C, Durand PG, Pereira C, Richard JC, Poupelin JC, Lemasson S, Badet M, Philit F, Vecellio L, and Chantrel G: Effects of inhaled fenoterol and positive end-expiratory pressure on the respiratory mechanics of patients with chronic obstructive pulmonary disease. Can Respir J. 2005; 12:329-335.
103. Dhand R, and Tobin MJ: Bronchodilator delivery with metered-dose inhalers in mechanically-ventilated patients. Eur Respir J. 1996;9:585-595.
104. Wright P, Carmichael L, and Bernard G: Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest. 1994;106:1517-1523.
105. Morina P, Herrera M, Venegas J, Mora D, Rodriguez M, and Pino E: Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med. 1997;23:58-64.
106. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) clinical trials network: Randomized, placebo-controlled clinical trial of an aerosolized beta-2 agonist for treatment of acute lung injury. Am J Respir Crit Care Med. 2011;184:567-568.
107. Bates J, Rossi A, and Milic-Emili J: Analysis of the behavior of the respiratory system with constant inspiratory flow. J Appl Physiol. 1985;58:1840-1848.
108. Bates J, and Milic-Emili J: The flow interruption technique for measuring respiratory resistance. J Crit Care. 1991;6: 227-238.
109. Kondili E, Alexopoulou C, Prinianakis G, Xirouchaki N, Vaporidi K, and Georgopoulos D: Effect of albuterol on expiratory resistance in mechanically ventilated patients. Respir Care. 2011;56:626-632.
110. Conti G, Dell'Utri D, Vilardi V, De Blasi RA, Pelaia P, Antonelli M, Bufi M, Rosa G, and Gasparetto A: Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients. Acta Anaesthesiol Scand. 1993;37:105-109.
111. Mouloudi E, Prinianakis G, Kondili E, and Georgopoulos D: Effect of inspiratory flow rate on beta2-agonist induced bronchodilation in mechanically ventilated COPD patients. Intensive Care Med. 2001;27:42-46.